ENDPOINTS

J&J wins patent feud against Viatris over schizophrenia drug

Johnson & Johnson scored an appeals court win in its bid to block generic competition for its long-acting schizophrenia drug. The US Court of Appeals for the Federal Circuit on Friday

Mar 28, 2025 - 18:08
 0
J&J wins patent feud against Viatris over schizophrenia drug
Johnson & Johnson scored an appeals court win in its bid to block generic competition for its long-acting schizophrenia drug. The US Court of Appeals for the Federal Circuit on Friday
Read More

Tags:

Previous Article

NASA astronaut who gave up seat for Starliner rescue mission takes command of Sp...

Next Article

What next for the energy transition in the US?

Related Posts

Ophthalmology startup Character Biosciences gets $93M for genetics-based approach

Ophthalmology startup Character Biosciences gets $93M f...

Mar 25, 2025  0

#CROI25: Merck’s troubled HIV drug heads to regulators; ViiV seeks longer-acting HIV drug

#CROI25: Merck’s troubled HIV drug heads to regulators;...

Mar 12, 2025  0

Is the GLP-1 compounding boom over? Not exactly

Is the GLP-1 compounding boom over? Not exactly

Feb 25, 2025  0